Trial intelligence / Profile preview

Randomized Phase 3 Study of Oral Azacitidine vs Investigator’s Choice in Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma

2017-003909-17Phase 3Completed

Sponsor

LYSARC

Start

Aug 2018

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules

Countries

1